319 related articles for article (PubMed ID: 15368958)
21. Senescence and immortalization: role of telomeres and telomerase.
Shay JW; Wright WE
Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900
[TBL] [Abstract][Full Text] [Related]
22. Analysis of telomerase activity and telomere function in cancer.
Gordon KE; Parkinson EK
Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
[TBL] [Abstract][Full Text] [Related]
23. Telomere instability and cancer.
Londoño-Vallejo JA
Biochimie; 2008 Jan; 90(1):73-82. PubMed ID: 17728038
[TBL] [Abstract][Full Text] [Related]
24. Telomerase and cancer.
Testorelli C
J Exp Clin Cancer Res; 2003 Jun; 22(2):165-9. PubMed ID: 12866565
[TBL] [Abstract][Full Text] [Related]
25. Telomere dysfunction in genome instability syndromes.
Callén E; Surrallés J
Mutat Res; 2004 Sep; 567(1):85-104. PubMed ID: 15341904
[TBL] [Abstract][Full Text] [Related]
26. Telomeres: hallmarks of radiosensitivity.
Ayouaz A; Raynaud C; Heride C; Revaud D; Sabatier L
Biochimie; 2008 Jan; 90(1):60-72. PubMed ID: 18006207
[TBL] [Abstract][Full Text] [Related]
27. Protection against chromosome degradation at the telomeres.
Grandin N; Charbonneau M
Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802
[TBL] [Abstract][Full Text] [Related]
28. Telomeres rather than telomerase a key target for anti-cancer therapy?
Boukamp P; Mirancea N
Exp Dermatol; 2007 Jan; 16(1):71-9. PubMed ID: 17181645
[TBL] [Abstract][Full Text] [Related]
29. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
[TBL] [Abstract][Full Text] [Related]
30. Telomerase activity in patients with chronic myeloid leukemia and lymphoma.
Bitisik O; Yavuz S; Yasasever V; Dalay N
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):3-12. PubMed ID: 11334367
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of telomeric instability.
Baird DM
Cytogenet Genome Res; 2008; 122(3-4):308-14. PubMed ID: 19188700
[TBL] [Abstract][Full Text] [Related]
32. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
[TBL] [Abstract][Full Text] [Related]
33. Telomeres and telomerase: a dual role in hepatocarcinogenesis.
Satyanarayana A; Manns MP; Rudolph KL
Hepatology; 2004 Aug; 40(2):276-83. PubMed ID: 15368430
[TBL] [Abstract][Full Text] [Related]
34. Strategies of treating cancer by cytokine regulation of chromosome end remodelling.
Liu JP; Nicholls C; Chen SM; Li H; Tao ZZ
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):88-92. PubMed ID: 19566820
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of telomeric chromatin at the crossroads of aging and cancer.
Ye J; Wu Y; Gilson E
Essays Biochem; 2010 Sep; 48(1):147-64. PubMed ID: 20822492
[TBL] [Abstract][Full Text] [Related]
36. Correlation of telomerase activity and telomere length to chemosensitivity.
Kiyozuka Y
Methods Mol Med; 2005; 111():97-108. PubMed ID: 15911975
[TBL] [Abstract][Full Text] [Related]
37. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation.
Smith LL; Coller HA; Roberts JM
Nat Cell Biol; 2003 May; 5(5):474-9. PubMed ID: 12717449
[TBL] [Abstract][Full Text] [Related]
38. Telomeres and telomerase in cancer stem cells.
Ju Z; Rudolph KL
Eur J Cancer; 2006 Jun; 42(9):1197-203. PubMed ID: 16644207
[TBL] [Abstract][Full Text] [Related]
39. Multiple mechanisms of telomere maintenance exist in liposarcomas.
Johnson JE; Varkonyi RJ; Schwalm J; Cragle R; Klein-Szanto A; Patchefsky A; Cukierman E; von Mehren M; Broccoli D
Clin Cancer Res; 2005 Aug; 11(15):5347-55. PubMed ID: 16061847
[TBL] [Abstract][Full Text] [Related]
40. Telomerase: not just for the elongation of telomeres.
Calado RT; Chen J
Bioessays; 2006 Feb; 28(2):109-12. PubMed ID: 16435298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
